Sort
50,496 grants matching “lung cancer”
Immunology Team Contributions to the LSB
$633,676Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS
$633,642Pamela Ann Madden · Washington University · R01 · FY2012 · DA
Role of METTL3 and the m6A Epitranscriptome in cancer
$633,635Richard I. Gregory · Boston Children'S Hospital · R01 · FY2022 · CA
Regulation of polarity by Sonic hedgehog morphogen signaling
$633,625Andrew P McMahon · University Of Southern California · R01 · FY2016 · NS
Regulation of polarity by Sonic hedgehog morphogen signaling
$633,625Andrew P McMahon · University Of Southern California · R01 · FY2015 · NS
Fostering collaborations and the career of a newly recruited pulmonary scientist
$633,498Richard J Martin · National Jewish Health · P30 · FY2009 · HL
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
$633,492Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2016 · CA
Liquid biopsy and radiomics for liver cancer surveillance
$633,414Augusto Villanueva · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA
Population Modeling of Bladder Cancer Detection and Control
$633,411Thomas Trikalinos · Brown University · U01 · FY2024 · CA
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
$633,309Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2012 · CA
Cook County Hospital, Department of Surgery, MD-CCOP
$633,245Hektoen Institute For Medical Research · U10 · FY2004 · CA
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
$633,229Esther H Chang · Georgetown University · R01 · FY2009 · CA
Clinical trials employing cancer vaccine combination therapies
$633,201James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Impact of mutation burden on cancer growth and the immune landscape
$633,201Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Lung cancer molecular markers by sex: intergroup study
$633,153Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA
IGF::OT::IGF DEVELOPMENT OF MULTIANTIGEN VACCINES TO PREVENT THE DEVELOPMENT OF LUNG ADENOCARCINOMAS DRIVEN BY EITHER K-RAS OR EGFR ONCOPROTEINS IN MICE.
$633,081Dr. Ming You · Medical College Of Wisconsin · N01 · FY2015 · CA
Advancing Tobacco Use Treatment for African American Smokers
$633,057Lisa Sanderson Cox · University Of Kansas Medical Center · R01 · FY2017 · DA
The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data
$632,981Howard Fine · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
The role of Tet1 in myofibroblast differentiation
$632,950Sem H Phan · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
The role of Tet1 in myofibroblast differentiation
$632,950Sem H Phan · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Adenocarinoma of the Lung in Women
$632,943Wayne State University · R01 · FY2005 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$632,887Joel L Weissfeld · · N01 · FY2009 · CA
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
$632,571Pierre P Massion · Vanderbilt University · U01 · FY2010 · CA
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
$632,559Connie C. W. Hsia · Ut Southwestern Medical Center · U01 · FY2015 · HL
Improving smoking abstinence outcomes in the African American community through extended treatment
$632,504Lisa Sanderson Cox · University Of Kansas Medical Center · R01 · FY2023 · CA